Showing 4 results for Skin Disorder
, , , ,
Volume 5, Issue 4 (1-2015)
Abstract
Age related skin disorders due to structural and functional changes in the skin of the elderly may increase health care costs. As a result of an increase in the number of aging population in Iran, provision of dermatology services to the elderly group due to the limitation of resources and the high cost of those services will be a challenge for the health care system.
Moreover, by increasing the elderly residents in private nursing homes, problems of the providing dermatology services costs as well as limitations in physical performance of the elderly to receive specialized services, the necessity of the existence of alternative and low-cost solutions to meet the needs of this group, will help to clarify the importance of the issue.
By providing the facilities for physicians to examine the patients by telemedicine, access to medical care services (in broad geographic level) will be improved besides transferring of the patients for medical centers and the cost of physician care will be reduced
Kiana Shomali, Atefeh Naeimifar, Saman Ahmadnasrollahi,
Volume 12, Issue 4 (2-2022)
Abstract
Alterations in barrier function are associated with a number of skin diseases, including xerosis, atopic dermatitis, and psoriasis. Urea, a component of the natural moisturizing factor of the skin, plays an important role in the preservation of skin hydration and integrity. Several studies have investigated the effects of urea in the clinical setting. Here, we summarize the available clinical evidence regarding the effects of urea in the maintenance of healthy skin and management of skin disorders. At lower doses (≤10%),
urea-containing topical formulations act as a skin moisturizer, while at higher concentrations (>10% urea), urea-based preparations exert a keratolytic action. Urea is also useful in combination therapies with anti-inflammatory and anti-fungal drugs, due to its activity as a penetration enhancer.
Parham Tamimi,
Volume 14, Issue 3 (11-2023)
Abstract
Parkinson Disease (PD) is a neurological disorder, which have comorbidity with some skin disorders. Skin disorders in Parkinson can be divided into two main groups including 1) non-iatrogenic disorders: melanoma, seborrheic dermatitis, sweating disorders, pemphigoid, rosacea, and 2) Iatrogenic disorders due to anti-Parkinson drugs side effects (like: carbidopa/levodopa, rotigotine, other dopamine agonists, COMT inhibitors and SC Apo morphine).
While seborrheic dermatitis is considered as a pre diagnostic sign, rosacea can be assumed as a warning sign of disease development. In addition, a strong correlation between PD and further bolus pemphigoid has been discovered. There might be a relation between melanoma and PD. It is important especially in patients with lighter skin with red and blond hair color. Hence, physicians should pay special attention in these patients and try to increase awareness in this population like reminding the importance of sun protection.
Maryam Nourizadeh, Mahsa Fattahi,
Volume 14, Issue 4 (2-2024)
Abstract
Methotrexate (MTX) is a freely available medication. However, regardless of extensive off-label consumption, FDA labeling does not include accepted for the consumption of MTX for many inflammatory skin diseases in pediatrics, containing morphea, psoriasis, atopic dermatitis, and alopecia areata. Lacking published healing recommendations makes the clinicians unsure about prescribing MTX in an off-label manner especially in children. Present study, was conducted to review the use of MTX to heal pediatric inflammatory skin disorders.
The evidence and consent based advices will assistance safe and successful use of MTX for the underserved population of pediatrics who may benefit from this valuable, time-honored medication.
